BBIO vs OMC · rev $221.9M vs rev $17.27B
BridgeBio Pharma Inc (BBIO) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
BBIO currently screens at market cap $13.24B. OMC currently screens at market cap $21.75B.
Not investment advice. Open the BBIO and OMC stock pages for the full models.
Not investment advice.